Results 171 to 180 of about 125,630 (346)

The cost‐effectiveness of intraoperative margin assessment strategies during radical prostatectomy

open access: yesBJU International, EarlyView.
Objective To determine whether current intraoperative margin assessment (IOMA) techniques (such as Neurovascular Structure Adjacent Frozen‐section Examination [NeuroSAFE] or confocal laser microscopy [CLM]) used during radical prostatectomy (RP) to enhance nerve‐sparing surgery (NSS) while reducing positive surgical margins (PSMs) justify their extra ...
Joost van Drumpt   +7 more
wiley   +1 more source

Urinary bladder spindle-cell neoplasm concomitant with urothelial cancer

open access: diamond, 2013
Jeng-Sheng Chen   +6 more
openalex   +1 more source

Longitudinal Impact of Urinary Diversion on Health‐Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan

open access: yesCancer Science, EarlyView.
This multicenter prospective study examined the impact of urinary diversion on HRQOL among bladder cancer patients who underwent radical cystectomy. Evaluation using the BCI clarified changes in HRQOL related to urinary, bowel, and sexual domains before surgery and at 3, 6, and 12 months postoperatively.
Shuhei Yamada   +32 more
wiley   +1 more source

Urinary Tumor DNA to Identify Candidates for Repeat Transurethral Resection in Non‐Muscle‐Invasive Bladder Cancer

open access: yesCancer Science, EarlyView.
Urinary tumor DNA (utDNA) represents a powerful noninvasive biomarker to refine the need for repeat TURBT in high‐risk NMIBC. In our cohort of 161 patients, utDNA testing achieved superior accuracy to cytology, strongly predicted residual disease and recurrence, and could safely reduce unnecessary repeat resections by up to one‐third.
Zihan Xue   +8 more
wiley   +1 more source

Impact of Implementing Paris System on Diagnostic Precision and Management of Urinary Bladder Neoplasms. [PDF]

open access: yesIndian J Surg Oncol
Arora S   +5 more
europepmc   +1 more source

Perspectives For Target Therapy In The Treatment Of Malignant Neoplasms Of The Urinary Bladder

open access: diamond, 2018
Olga Antonova   +4 more
openalex   +2 more sources

Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real‐World Analysis in Japanese Patients

open access: yesCancer Science, EarlyView.
In this study, we investigated the predictive value of tumor mutational burden (TMB) for assessing the efficacy of pembrolizumab in a Japanese cohort. We analyzed real‐world data from 63,952 patients registered in the C‐CAT database who underwent comprehensive genomic profiling, and evaluated the therapeutic efficacy of pembrolizumab in 1899 of these ...
Tomoyo Yasuda   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy